:::

詳目顯示

回上一頁
題名:由藥師輔助實踐嚴重敗血症與敗血性休克治療指引成效
書刊名:臺灣臨床藥學雜誌
作者:劉人瑋洪惠風王春玉
作者(外文):Liu, Jen-weiHung, Huei-fongWang, Chun-yu
出版日期:2007
卷期:15:1
頁次:頁55-71
主題關鍵詞:敗血症敗血性休克治療指引SepsisSeptic shockGuidelines
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:25
期刊論文
1.Van den Berghe, Greet、Wilmer, Alexander、Hermans, Greet、Meersseman, W.、Wouters, P. J.、Milants, I.、Van Wijngaerden, E.、Bobbaers, H.、Bouillon, R.(20060202)。Intensive Insulin Therapy in the Medical ICU。The New England Journal of Medicine,354(5),449-461。  new window
2.Van den Berghe, Greet、Wouters, Pieter、Weekers, Frank、Verwaet, Charles、Bruyninckx, Frans、Schetz, Miet、Vlasselaers, D.、Ferdinande, P.、Lauwers, P.、Bouillon, R.(20011108)。Intensive Insulin Therapy in Critically Ill Patients。The New England Journal of Medicine,345(19),1359-1367。  new window
3.Martin, G. S.、Mannino, D. M.、Eaton, S.、Moss, M.(2003)。The epidemiology of sepsis in the United States from 1979 through 2000。N Engl J Med,348,1546-1554。  new window
4.Rivers, E.、Nguyen, B.、Havstad, S.、Ressler, J.、Muzzin, A.、Knoblich, B.、Peterson, E.、Tomlanovich, M.(2001)。Early Goal-Directed Therapy Collaborative Group: Early goat-directed therapy in the treatment of severe sepsis, and septic Shock。N Engl J Med,345,1368-1377。  new window
5.Bernard, G. R.、Vincent, J. L.、Laterre, P. F.、LaRosa, S. P.、Dhainaut, J. F.、Lopez-Rodriguez, A.、Steingrub, J. S.、Garber, G. E.、Helterbrandt, J. D.、Ely, E. W.、Fisher, C. J.(2001)。Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group-Efficacy and safety of recombinant human activated protein C for severe sepsis。N Engl J Med,344,699-709。  new window
6.Abraham, E.、Laterre, P. F.、Garg, R.、Levy, H.、Talwar, D.、Trzaskoma, B. L.、Francois, B.、Guy, J. S.、Bruckmann, M.、Rea-Neto, A.、Rossaint, R.、Perrotin, D.、Sablotzki, A.、Arkins, N.、Utterback, B. G.、Macias, W. L.(2005)。Administration of Drotrecogin Alfa (Activated)in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death。N Engl J Med,353,1332-1341。  new window
7.Annane, D.、Sebille, V.、Charpentier, C.、Bollaert, P. E.、Francois, B.、Korach, J. M.、Capellier, G.、Cohen, Y.、Azoulay, E.、Troche, G.、Ghaumet-Riffaut, P.、Bellissant, E.(2002)。Effect of treatment with rlow .doses rof hydrocortisone and fludrocortisone .on mortality in patients with septic shocks。JAMA,288,862-871。  new window
8.Dellinger, R. P.、Garlet, J. M.、Masur, H.、Gerlach, H.、Calandra, T.、Gohen, J.、Gea-Banacloche, J.、Keh, D.、Marshall, J. C.、Parker, M. M.、Ramsay, G.、Zimmerman, J. L.、Vincent, J. L.、Levy, M. M.(2004)。Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic。Grit Care Med,32,858-873。  new window
9.Levy, M. M.、Fink, M. P.、Marshall, J. C. V.、Abraham, E.、Angus, D.、Cook, D.、Cohen, J.、Opal, S. M.、Vincent, J. L.、Ramsay, G.(2003)。SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference。Crit Care Med,31,1250-1256。  new window
10.Le Gall, J. R.、Lemeshow, S.、Saulnier, F.(1993)。A new Simplified Acute Physiology Score (SAPS II):based otva European/North American:multicenter。JAMA,270,2957-2963。  new window
11.Vincent, J. L.、De Mendonca, A.、Cantraine, F.、Moreno, R.、Takala, J.、Suter, P. M.、Sprung, C. L.、Colardyn, F.、Blecher, S.(1998)。Use of the SOFA score to assess the incidence of organ dysfunction failure in intensive care units: results of a muiticenter, prospective study。Critical Care Medicine,26(11),1793-1800。  new window
12.Nguyen, H. B.、Rivers, E. P.、Abrahamian, F. M.、Moran, G. J.、Abraham, E.、Trzeciak, S.、Huang, D. T.、Osborn, T.、Stevens, D.、Talan, D. A.(2006)。Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines。Ann Emerg Med,48,28-54。  new window
13.Shapiro, N. I.、Howell, M. D.、Talmor, D.、Lahey, D.、Ngo, L.、Buras, J.、Wolfe, R. E.、Weiss, J. W.、Lisbon, A.(2006)。Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol。Crit Care Med,34,1025-1032。  new window
14.Dorin, R. I.、Qualls, C. R.、Crapo, L. M.(2003)。Diagnosis of adrenal insufficiency。Ann Intern Med,139,194-204。  new window
15.Finney, S. J.、Zekveld, C.、Elia, A.、Evans, T. W.(2003)。Glucose control and mortality in critically ill patients。JAMA,290,2041-2047。  new window
16.Vincent, J. L.、Sakr, Y.、Sprung, C. L.、Ranieri, V. M.、Reinhart, K.、Gerlach, H.、Moreno, R.、Carlet, J.、Le Gall, J. R.、Payen, D.(2006)。Sepsis Occurrence in Acutely III Patients Investigators Sepsis in European intensive care units: results of the SOAP study。Crit Care Med,34,344-353。  new window
17.Brun-Buisson, G.、Meshaka, P.、Pinton, P.、Vallet, B.(2004)。EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units。Intensive Care Med,30,580-588。  new window
18.Finfer, S.、Bellomo, R.、Lipman, J.、French, C.、Dobb, G.、Myburgh, J.(2004)。Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units。Intensive Care Med,30,589-596。  new window
19.Brower, R. G.、Matthay, M. A.、Morris, A.、Schoenfeld, D.、Thompson, B. T.、Wheeler, A.(2000)。Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome。The New England Journal of Medicine,342(18),1301-1308。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE